LRRK2 and Parkinson disease: The interaction between LRRK2 and 14-3-3 proteins plays a crucial role in maintaining LRRK2 in an inactive conformation, but PD-associated LRRK2 mutations destabilize this interaction, leading to increased kinase activity (57).